Investment Rating - The industry investment rating for basic chemicals and oil & gas is maintained at "Overweight" [6] Core Viewpoints - The industry is experiencing a bottoming phase in profitability for bulk chemicals in 2024, with signs of recovery in downstream demand beginning in Q1 2025 [2][19] - The oil price has been under pressure due to geopolitical tensions and OPEC+ production cuts, leading to a decline in profitability across the oil and gas value chain [10][14] - The overall revenue for the basic chemicals and oil & gas sector in 2024 was 1,031.71 billion, with a net profit of 49.85 billion, reflecting a year-on-year decline of 1% and 0.8% respectively [12][18] Summary by Sections 2024 Annual Overview - The oil and gas sector remains relatively strong, while bulk cyclical products are facing profitability challenges [3][14] - The chemical industry is waiting for a supply-demand turning point, with 21 out of 35 sub-industries showing positive performance in A-shares [14][16] Q1 2025 Performance - In Q1 2025, the oil price decline has led to a decrease in profitability for the oil and gas sector, while downstream products are showing initial signs of recovery [19][20] - The revenue for Q1 2025 was 25,157 billion, with a net profit of 1,426 billion, indicating a year-on-year decline of 4% and 3% respectively, but a quarter-on-quarter increase of 2% and 78% [12][23] Industry Outlook - The second half of 2025 is expected to see an upward trend, driven by improved domestic and external demand, as well as capital expenditure recovery [5][10] - Recommended stocks include Meihua Biological, Xinghuo Technology, and others, which are expected to benefit from the recovery in the chemical industry [8][5]

Group 1: Financial Performance and Market Conditions - The company reported a significant increase in costs in Q1 2025 due to changes in product volume and structure, leading to a year-on-year increase in total costs [2] - Despite a year-on-year increase in production and sales volume, the company's profit declined due to a drop in the selling prices of some chemical products, which fell more than the decrease in raw material procurement prices [2] - The company has implemented flexible production scheduling in response to market changes and product profitability levels [2] Group 2: Product and Market Strategy - The company is enhancing its product scale competitiveness and risk resistance through the production of Nylon 6 and organic silicon, despite market price fluctuations [2] - The company aims to respond to market changes by adjusting product output and structure, focusing on efficiency and cost reduction [3] - The company has a target of "outperforming the market and industry average" and is actively engaging in benchmarking improvement actions [3] Group 3: Shareholder Engagement and Corporate Governance - The company plans to implement its dividend scheme within two months after the annual shareholders' meeting on May 23, 2024 [2] - The company has publicly released its Environmental, Social, and Governance (ESG) reports for three consecutive years, detailing its management in these areas [3] - The company is committed to complying with relevant laws and regulations regarding capital operations and will disclose information accordingly [2]

Group 1 - The company is expected to achieve significant profit recovery in 2024, with a projected revenue of 29.76 billion yuan (up 17.4% year-on-year) and a net profit attributable to shareholders of 2.03 billion yuan (up 147.8% year-on-year) [1] - In Q1 2025, the company anticipates a revenue of 7.29 billion yuan (up 8.0% year-on-year, down 10.9% quarter-on-quarter) and a net profit of 410 million yuan (down 27.3% year-on-year, down 9.0% quarter-on-quarter) [1] Group 2 - The chemical new materials segment generated a revenue of 20.366 billion yuan in 2024 (accounting for 68% of total revenue, up 27% year-on-year) with a gross margin of 16% (up 1 percentage point year-on-year) [2] - The polycarbonate market is experiencing supply-demand imbalance and low prices, while the nylon 6 industry is growing rapidly but facing intense competition [2] - The company successfully launched its caprolactam and nylon 6 phase I project, and the organic silicon project was smoothly put into production [2] Group 3 - The basic chemicals segment reported a revenue of 5.795 billion yuan in 2024 (accounting for 19% of total revenue, down 7% year-on-year) with a gross margin of 17% (up 3 percentage points year-on-year) [3] - The fertilizer segment achieved a revenue of 3.065 billion yuan (accounting for 10% of total revenue, up 18% year-on-year) with a gross margin of 6% (down 1 percentage point year-on-year) [3] - The increase in fertilizer revenue was driven by new projects and improved market conditions, although profitability slightly declined [3]

Investment Rating - The report maintains a "Buy" rating for the company [1] Core Views - The company's main product prices have declined, leading to a decrease in performance for the second half of 2024 and the first quarter of 2025 [6] - In 2024, the company achieved a revenue of 29.763 billion yuan, a year-on-year increase of 17.37%, and a net profit attributable to shareholders of 2.029 billion yuan, a year-on-year increase of 148% [5] - The company is expected to face challenges in 2025 due to further price declines in key products, resulting in a downward adjustment of profit forecasts for 2025-2026 [7] Summary by Sections Financial Performance - In 2024, the company reported a revenue of 29.763 billion yuan, with a net profit of 2.029 billion yuan, reflecting a significant year-on-year growth of 148% [5] - The first quarter of 2025 saw a revenue of 7.290 billion yuan, a year-on-year increase of 7.96%, but a quarter-on-quarter decrease of 10.92% [5] Business Segments - The chemical new materials segment generated a revenue of 20.4 billion yuan in 2024, up 26.8% year-on-year, while the basic chemical products segment saw a revenue of 5.8 billion yuan, down 7.4% year-on-year [6] - The fertilizer business achieved a revenue of 3.07 billion yuan, a year-on-year increase of 17.9% [6] Price Trends - The report highlights a decline in sales prices for key products in the second half of 2024 and the first quarter of 2025, with specific declines noted for PC, PA6, and other chemicals [6] Production Capacity and Management - The company has successfully resumed production of its hydrogen peroxide facility and launched new capacity projects, including a 600,000-ton caprolactam project [7] - The production target for 2025 is set at 13.5 million tons, a 40.6% increase from 2024 [7] Profit Forecasts - The profit forecasts for 2025-2027 have been adjusted downward due to the decline in product prices, with expected net profits of 2.056 billion yuan for 2025, 2.325 billion yuan for 2026, and 2.643 billion yuan for 2027 [7]

Core Viewpoint - The company reported a revenue of 29.763 billion yuan for 2024, representing a year-on-year growth of 17.4%, with a net profit attributable to shareholders of 2.029 billion yuan, corresponding to an earnings per share of 1.06 yuan, which is a significant increase of 147.8% year-on-year [1] Financial Performance - For 2024, the company's revenue was 29.763 billion yuan, with a net profit of 2.029 billion yuan, and earnings per share of 1.06 yuan, marking a 147.8% increase year-on-year [1] - In Q4 2024, revenue reached 8.184 billion yuan, with a quarter-on-quarter growth of 10.4% and a year-on-year growth of 8.6%, while net profit was 454 million yuan, showing a quarter-on-quarter increase of 45.5% and a year-on-year increase of 12.5% [1] - For Q1 2025, revenue was 7.290 billion yuan, with a quarter-on-quarter increase of 8.0% but a year-on-year decrease of 10.9%, and net profit was 413 million yuan, reflecting a quarter-on-quarter decrease of 27.3% and a year-on-year decrease of 9.0% [1] Cost Structure - In 2024, the company's sales expenses increased by 29.5%, while management expenses decreased by 3.8%, financial expenses decreased by 36.5%, and R&D expenses increased by 3.0% [1] - The reduction in financial expenses was primarily due to a decrease in interest-bearing debt and borrowing rates [1] Product Performance - The company experienced growth in chemical and fertilizer product sales, with revenues from chemical new materials, basic chemicals, and fertilizers increasing by 26.8%, -7.4%, and 17.9% year-on-year, respectively [2] - The total sales volume for chemical manufacturing and fertilizer manufacturing reached 5.0226 million tons and 1.9001 million tons, representing year-on-year increases of 13.0% and 37.6%, respectively [2] - The increase in production capacity from the company's caprolactam and nylon-6 project contributed significantly to sales growth [2] Market Trends - Formic acid prices have been on the rise, benefiting leading companies in the sector, with average prices increasing from 2,426 yuan/ton in Q3 2024 to 3,250 yuan/ton by April 25, 2025 [3] - The company is a leading producer of formic acid with an annual capacity of 400,000 tons and a market share exceeding 50% [3] - The company has ongoing projects valued at 4.760 billion yuan, including organic silicon and downstream ethylene integration projects, which are expected to contribute to future growth [3] Profit Forecast and Valuation - Due to a decline in prices for products like dibutyl phthalate, the company's net profit forecast for 2025 has been reduced by 28% to 1.730 billion yuan [4] - The 2026 profit forecast is set at 1.972 billion yuan, with the current stock price corresponding to a P/E ratio of 12.7 for 2025 and 11.1 for 2026 [4] - The target price is maintained at 14.50 yuan, reflecting a potential upside of 26.5% based on the projected P/E ratios for 2025 and 2026 [4]

Group 1: Company Performance Overview - The company achieved an operating income of approximately 29.763 billion yuan in 2024, representing a year-on-year growth of 17.37% [1] - The net profit attributable to shareholders was about 2.029 billion yuan, with a significant year-on-year increase of 147.79% [2] - The net profit excluding non-recurring gains and losses was approximately 1.962 billion yuan, reflecting a year-on-year growth of 126.9% [2] Group 2: Q1 2025 Performance - In Q1 2025, the company reported an operating income of around 7.29 billion yuan, marking a year-on-year increase of 7.96% [2] - The net profit attributable to shareholders for Q1 2025 was approximately 413 million yuan, showing a decline of 27.3% compared to the previous year [2] - The net profit excluding non-recurring gains and losses for Q1 2025 was about 384 million yuan, which is a decrease of 33.81% year-on-year [2] Group 3: Market Conditions and Product Pricing - The chemical product prices have fluctuated recently due to changes in peer company operating rates and downstream demand [1] - The company is adapting its production and sales strategies based on market conditions to mitigate risks and seize opportunities [1] Group 4: Dividend Policy - The profit distribution plan for 2024 proposes a cash dividend of 3.50 yuan (including tax) for every 10 shares based on the total share capital at the end of 2024 [2] - The company will determine future dividend plans in accordance with regulatory requirements and its operational needs [2]

证券代码：000830 证券简称：鲁西化工 公告编号：2025- 033 鲁西化工集团股份有限公司 关于举办2024年度暨2025年一季度业绩说明会的公告 本公司及董事会全体成员保证信息披露的内容真实、准 确、完整，没有虚假记载、误导性陈述或重大遗漏。 重要内容提示： 鲁西化工集团股份有限公司（以下简称"公司"）已于 2025 年 4 月 26 日在巨潮资讯网上披露了《2024 年年度报告》及《2025 年一季度报告》。为便于广大投资者更加全面深入地了解公司经 营业绩、发展战略等情况，公司定于 2025 年 5 月 6 日（星期二） 会议召开时间：2025 年 5 月 6 日（星期二）15:30-16:30 会议召开方式：网络互动方式 会议召开地点：价值在线（www.ir-online.cn） 会议问题征集：投资者可于 2025 年 5 月 6 日前访问网址 https://eseb.cn/1nOgsSvNeFO 或使用微信扫描下方小程 序码进行会前提问，公司将通过本次业绩说明会，在信息 披露允许范围内就投资者普遍关注的问题进行回答。 15:30-16:30 在"价值在线"（www.ir-online.cn） ...

①化工新材料：核心增长引擎 公司化工新材料产品包括 聚碳酸酯（PC）、尼龙 6、己内酰胺、多元醇（正丁醇、辛醇、新戊二醇等）、有机硅材料和氟材料（六氟丙烯、聚全氟乙 丙烯、聚四氟乙烯、二氟甲烷等） 。报告期内， 己内酰胺·尼龙 6 一期工程 开车成功满负荷运行， 40万吨有机硅项目 顺利打通全流程， 24万吨乙烯 下游一体化项目 、 15 万吨丙酸等项目 有序推进， 30万吨双氧水装置 恢复生产。 报告期内， 化工新材料板块营收203.66亿元，同比增长26.83%，占总营收68.43% ，毛利率16%（同比+1个百分点） ②基础化工：价格承压，营收下滑 【DT新材料】 获悉，4月26日， 鲁西化工 发布公告，2025年第一季度，公司实现营业收入为72.90亿元，同比上升7.96%；归母净利润为4.13亿元， 同比下降27.30%；扣非归母净利润为3.84亿元，同比下降33.81%。 | | 本报告期 | 上年同期 | 本报告期比上年同 | | --- | --- | --- | --- | | | | | 期增减(%) | | 营业收入(元) | 7,289,926,095.44 | 6,752,410,7 ...

Investment Rating - The report maintains a "Buy" rating for the company with a target price of 14.98 RMB [7][8]. Core Views - The company achieved a significant increase in net profit for 2024, with a year-on-year growth of 148%, reaching 2.03 billion RMB. The revenue for the same period was 29.76 billion RMB, up 17% year-on-year [1]. - The first quarter of 2025 saw a revenue of 7.29 billion RMB, an 8% increase year-on-year, although net profit decreased by 27% to 410 million RMB due to substantial inventory impairment losses [1][4]. - The company is expected to benefit from integrated production and scale advantages, with new capacity gradually coming online, which is anticipated to drive performance growth [1][4]. Summary by Sections Financial Performance - In 2024, the company reported a revenue of 29.76 billion RMB and a net profit of 2.03 billion RMB, with the fourth quarter revenue at 8.18 billion RMB, reflecting a 10% year-on-year increase [1]. - The first quarter of 2025 showed a revenue of 7.29 billion RMB, an 8% increase year-on-year, but a 27% decline in net profit compared to the previous year [1][3]. Price Trends and Market Conditions - Average prices for various products, including butanol and DMF, declined in 2024 due to increased supply, with most products experiencing price drops [2][3]. - The company’s new projects, particularly in nylon production, are expected to contribute positively to revenue growth [2]. Cost Management and Future Prospects - The cost side of coal chemical production showed improvement in the first quarter of 2025, with significant price drops in raw materials like coal [3]. - New projects, including a 400,000-ton organic silicon project, are expected to come online and contribute to future growth [3]. Profit Forecast and Valuation - The report maintains profit forecasts for 2025-2027, estimating net profits of 2.0 billion RMB, 2.3 billion RMB, and 2.6 billion RMB respectively, with corresponding EPS of 1.07 RMB, 1.22 RMB, and 1.39 RMB [4][6]. - The target price of 14.98 RMB is based on a 14x PE ratio for 2025, reflecting the company's integrated advantages and potential from new projects [4].

Investment Rating - The report maintains a "Buy" rating for the company with a target price of 14.98 RMB [7][8]. Core Views - The company achieved a significant increase in net profit for 2024, with a year-on-year growth of 148%, reaching 2.03 billion RMB. The revenue for the same period was 29.76 billion RMB, up 17% year-on-year [1]. - The first quarter of 2025 saw a revenue of 7.29 billion RMB, an 8% increase year-on-year, although net profit decreased by 27% to 410 million RMB due to substantial inventory impairment losses [1][4]. - The company is expected to benefit from integrated production and scale advantages, with new capacity gradually coming online, which is anticipated to drive performance growth [1][4]. Summary by Sections Financial Performance - For 2024, the company reported a revenue of 29.76 billion RMB and a net profit of 2.03 billion RMB, with a proposed dividend of 0.35 RMB per share [1]. - The fourth quarter of 2024 showed a revenue of 8.18 billion RMB, a 10% increase year-on-year, and a net profit of 450 million RMB, up 46% year-on-year [1]. - The first quarter of 2025 reported a revenue of 7.29 billion RMB, an 8% increase year-on-year, but a net profit decline of 27% [1][3]. Market Conditions - The average prices for various chemical products, including butanol and DMF, declined in 2024 due to oversupply, impacting revenue from the new materials and basic chemicals segments [2][3]. - The company’s new nylon 6 project and improved capacity utilization contributed to a 27% revenue increase in the new materials segment [2]. Cost Management - The cost side of the coal chemical sector showed improvement in the first quarter of 2025, with significant price drops in raw materials like power coal and lanthanum [3]. - The company has initiated new projects, including a 400,000-ton organic silicon project, which is expected to contribute to future revenue growth [3]. Profit Forecast and Valuation - The profit forecast for 2025-2027 estimates net profits of 2.0 billion, 2.3 billion, and 2.6 billion RMB respectively, with corresponding EPS of 1.07, 1.22, and 1.39 RMB [4][6]. - The report assigns a 14x PE ratio for 2025, reflecting the company's integrated advantages and potential from new projects, leading to a target price of 14.98 RMB [4].